Trending menu:
Most Read
Latest Content
August’s top news stories
Biopharmaceutical firm Retrophin reported that the Phase III clinical trial of fosmetpantotenate failed to meet endpoints in pantothenate kinase-associated neurodegeneration (PKAN) patients; and MyoKardia has commenced dosing of patients in a Phase I trial of small molecule MYK-224 for the treatment of hypertrophic cardiomyopathy (HCM). Clinicaltrialsarena.com wraps up the key headlines from August 2019.
Study assesses blood test to match patients to clinical trials
Researchers from the University of Manchester’s CRUK Manchester Institute are conducting a clinical study, dubbed TARGET, to evaluate the use of a blood test in matching cancer patients to appropriate clinical trials.
Close
Close
Close
Go Top
